Technical Analysis for EXAS - Exact Sciences Corporation

Grade Last Price % Change Price Change
grade A 96.88 3.06% 2.88
EXAS closed up 3.06 percent on Friday, May 24, 2019, on 77 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical EXAS trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Morning Star Bullish 0.00%
Gapped Up Strength 0.00%
Fell Below 50 DMA Bearish 3.06%
Hammer Candlestick Bullish 3.06%
Doji - Bullish? Reversal 3.06%
Gapped Down Weakness 3.06%
NR7 Range Contraction 2.08%
20 DMA Resistance Bearish -0.07%
Shooting Star Candlestick Bearish -0.07%

Older signals for EXAS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test includes proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company's stool-based DNA colorectal cancer screening technology also focuses on the inflammatory bowel disease. It has collaboration, license, and purchase agreement with Genzyme Corporation, as well as with Mayo Clinic for developing tests to detect other gastro-intestinal cancers, primarily esophageal and pancreatic cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Medicine Health Cancer Medical Tests Inflammatory Bowel Disease Pancreatic Cancer Colorectal Cancer Cancer Screening Diagnostic Gastroenterology Mayo Clinic Polyp
Is EXAS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 105.28
52 Week Low 47.78
Average Volume 1,720,062
200-Day Moving Average 78.8147
50-Day Moving Average 94.1702
20-Day Moving Average 97.6825
10-Day Moving Average 94.959
Average True Range 3.9851
ADX 12.17
+DI 24.5638
-DI 26.9433
Chandelier Exit (Long, 3 ATRs ) 93.3247
Chandelier Exit (Short, 3 ATRs ) 98.9753
Upper Bollinger Band 105.8981
Lower Bollinger Band 89.4669
Percent B (%b) 0.45
BandWidth 16.821027
MACD Line 0.175
MACD Signal Line 0.6102
MACD Histogram -0.4352
Fundamentals Value
Market Cap 11.53 Billion
Num Shares 119 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -75.10
Price-to-Sales 34.69
Price-to-Book 10.86
PEG Ratio -1.87
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 101.10
Resistance 3 (R3) 100.81 99.12 100.39
Resistance 2 (R2) 99.12 98.05 99.26 100.16
Resistance 1 (R1) 98.00 97.38 98.56 98.29 99.92
Pivot Point 96.31 96.31 96.59 96.45 96.31
Support 1 (S1) 95.19 95.24 95.75 95.48 93.84
Support 2 (S2) 93.50 94.57 93.64 93.60
Support 3 (S3) 92.38 93.50 93.37
Support 4 (S4) 92.67